Put companies on watchlist
Cenit AG
ISIN: DE0005407100
WKN: 540710
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

Cenit AG · ISIN: DE0005407100 · EQS - Analysts (69 News)
Country: Germany · Primary market: Germany · EQS NID: 16743
06 April 2023 11:32AM

BUY


Original-Research: Cenit AG - von GBC AG

Einstufung von GBC AG zu Cenit AG

Unternehmen: Cenit AG
ISIN: DE0005407100

Anlass der Studie: Research Report (Anno) Empfehlung: BUY
Kursziel: 19.75 EUR
Kursziel auf Sicht von: 31.12.2023
Letzte Ratingänderung:
Analyst: Cosmin Filker, Marcel Goldmann

- Clear corporate strategy for further growth in place - Strong increase in sales and earnings expected according to “CENIT 2025” - Slight price target increase
 
In the past business year 2022, CENIT AG achieved a significant increase in sales of 11.0% to € 162.15 million (previous year: € 146.07 million) and thus almost compensated for the sales dip of the past two business years. ISR Information Products AG, which was acquired on 31 May 2022, made the main contribution to the sales dynamics achieved. Since becoming part of the CENIT Group, ISR had contributed sales of € 13.57 million. Without inorganic effects, CENIT AG would have reported sales revenues of € 148.58 million and thus an organic sales increase of 1.7 %.  
Broken down by individual types of revenues, it becomes clear that the growth in revenues was achieved exclusively through the 39.9% increase in consulting and service revenues to € 55.72 million (previous year: € 39.82 million). This includes ISR sales as well as catch-up effects after the corona pandemic which had particularly affected this sales area. In contrast, no growth was achieved in sales of third-party software and CENIT software. It should be emphasised that the company has a high proportion of recurring revenues of € 79.68 million, which account for 49.1% of total revenues.
 
Despite the significant increase in revenues, EBIT improved only marginally by 1.1% to € 6.31 million (previous year: € 6.23 million). This is due in particular to increased costs in connection with the ISR acquisition, increased travel and vehicle costs, higher project costs for new software and one-off effects from the reorganisation of the company (approx. € 1.3 million). In addition, lower credits were received from tax incentives for R&D in Germany and France, and finally, the discontinuation of the short-time allowance, which was still around € 1.3 million in the previous year, also made itself felt. The EBIT margin in 2022 was 3.9% (previous year: 4.3%).
 
CENIT AG expects revenues of around € 180 million and an EBIT of more than € 9.5 million for 2023. At the same time, the 'CENIT 2025' agenda was confirmed, in which sales revenues of approximately € 300 million are expected by 2025, accompanied by an increase in the EBIT margin to 8% to 10%. We consider the company's guidance for 2023 to be very realistic, as the first full-year inclusion of ISR and the acquisition of mip in January 2023 can be expected to result in an increase in sales of approximately € 13 million. In addition to the implementation of various organisational and strategic measures, inorganic growth continues to play a very important role in the implementation of 'CENIT 2025'. According to the company's plans, two to three company acquisitions are to be made annually.  
Our revenue and earnings estimates up to the 2025 financial year are based on short- and medium-term corporate guidance. For 2023, we expect revenue of €181.61 million, rising to €233.91 million by 2025. We do not include inorganic growth, which explains the revenue gap to the expected €300 million. Therefore, we expect the EBIT margin to reach the lower half of the expected range by 2025, with an improving EBIT margin trend.  
Within the framework of our DCF valuation model, we have determined a new target price of € 19.75 (previously: € 18.20). The price target increase is exclusively a consequence of the first-time inclusion of the 2025 estimates in the concrete estimation period, which provides a higher basis for the continuity phase of the DCF valuation model. An even higher target price increase was countered by the increase in the weighted cost of capital to 8.99% (previously: 8.51%) as a result of the higher risk-free interest rate. We continue to assign the BUY rating.  

Die vollständige Analyse können Sie hier downloaden: http://www.more-ir.de/d/26743.pdf

Kontakt für Rückfragen

Offenlegung möglicher Interessenskonflikte nach § 85 WpHG und Art. 20 MAR Beim oben analysierten Unternehmen ist folgender möglicher Interessenkonflikt gegeben: (5a,6a,7,11); Einen Katalog möglicher Interessenkonflikte finden Sie unter: http://www.gbc-ag.de/de/Offenlegung.htm +++++++++++++++
Date and time of completion of the study: 06.04.2023 (09:58 am) Date and time of first transmission: 06.04.2023 (11:30 am)

-------------------übermittelt durch die EQS Group AG.-------------------

Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw. Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.

Visual performance / price development - Cenit AG
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2025
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.